O'Brien JA - Search Results

1

Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.

Caro JJ, Migliaccio-Walle K, O'Brien JA, Nova W, Kim J, Hauch O, Hillson E, Wedel H, Hjalmarson A, Gottlieb S, Deedwania PC, Wikstrand J; MERIT-HF Study Group. Caro JJ, et al. J Card Fail. 2005 Dec;11(9):647-56. doi: 10.1016/j.cardfail.2005.06.433. J Card Fail. 2005. PMID: 16360958

2

Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK.

Ward A, Caro JJ, Getsios D, Ishak K, O'Brien J, Bullock R; AHEAD Study Group. Ward A, et al. Int J Geriatr Psychiatry. 2003 Aug;18(8):740-7. doi: 10.1002/gps.919. Int J Geriatr Psychiatry. 2003. PMID: 12891643

3

Direct medical cost of managing deep vein thrombosis according to the occurrence of complications.

O'Brien JA, Caro JJ. O'Brien JA, et al. Pharmacoeconomics. 2002;20(9):603-15. doi: 10.2165/00019053-200220090-00004. Pharmacoeconomics. 2002. PMID: 12141888

4

Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000.

O'Brien JA, Patrick AR, Caro J. O'Brien JA, et al. Clin Ther. 2003 Mar;25(3):1017-38. doi: 10.1016/s0149-2918(03)80122-4. Clin Ther. 2003. PMID: 12852716

5

The cost of treating heart valve related complications.

Caro JJ, Migliaccio-Walle K, O'Brien JA. Caro JJ, et al. J Heart Valve Dis. 1996 Mar;5(2):122-7. J Heart Valve Dis. 1996. PMID: 8665002

6

Bileaflet valve replacement: complications and costs.

Migliaccio-Walle K, Klittich W, Banks J, O'Brien JA, Caro JJ. Migliaccio-Walle K, et al. Adv Ther. 1996 Jan-Feb;13(1):1-9. Adv Ther. 1996. PMID: 10163333

7

Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy.

Caro JJ, O'Brien JA, Migliaccio-Walle K, Raggio G. Caro JJ, et al. Pharmacoeconomics. 2001 Jan;19(1):95-104. doi: 10.2165/00019053-200119010-00007. Pharmacoeconomics. 2001. PMID: 11252549

8

Alzheimer's disease and other dementia in nursing homes: levels of management and cost.

O'Brien JA, Caro JJ. O'Brien JA, et al. Int Psychogeriatr. 2001 Sep;13(3):347-58. doi: 10.1017/s1041610201007736. Int Psychogeriatr. 2001. PMID: 11768381

9

Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.

Caro JJ, Getsios D, Caro I, Klittich WS, O'Brien JA. Caro JJ, et al. Diabet Med. 2004 Nov;21(11):1229-36. doi: 10.1111/j.1464-5491.2004.01330.x. Diabet Med. 2004. PMID: 15498090

10

Cost of managing an episode of relapse in multiple sclerosis in the United States.

O'Brien JA, Ward AJ, Patrick AR, Caro J. O'Brien JA, et al. BMC Health Serv Res. 2003 Sep 2;3(1):17. doi: 10.1186/1472-6963-3-17. BMC Health Serv Res. 2003. PMID: 12952552 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters